Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: A prospective, randomized controlled study

Teruhiko Yokoyama, Hiromi Kumon, Yoshitsugu Nasu, Hitoshi Takamoto, Toyohiko Watanabe

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: A prospective, randomized controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences